Orpington Eyecare centre are proud to announce the latest tool in Myopia management in the practice.

Childhood myopia is increasing at an alarming rate, impacting long-term eye health and quality of life. Early intervention is crucial, and the Eyerising Myopia Management Device offers a revolutionary, non-invasive solution.

Powered by patented Repeated Low-Level Red-Light (RLRL) therapy, this device slows myopia progression by up to 87.7% without medications, eyedrops, or contact lenses. Suitable for children aged 3 to 16, it is easy to use at home with just 3-minute sessions, twice daily. The device is clinically validated and free from significant side effects, making it a safe and effective choice for managing myopia.

Designed by an expert Australian MedTech team, it meets stringent regulatory standards across Europe, Australasia, and the UK. Take control of myopia and secure a brighter future for your child today.

Learn more at www.eyerisinginternational.com.

More information